nova pharmaceutical corp said patent office has allowed its patent for bradykinin antagonist drugs nova said patents have also been filed countries worldwide said has exclusive worldwide rights these patents for first bradykinin blocking drugs being developed topical pain relievers and nasal spry form for treating common cold symptoms nova said bradykinin most powerful paing producing substance body and considered based scientific evidence initial stimulus pain reuter 